As of close of business last night, IGC Pharma Inc’s stock clocked out at $0.35, up 1.99% from its previous closing price of $0.34. In other words, the price has increased by $+0.0068 from its previous closing price. On the day, 3893692 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
To gain a deeper understanding of IGC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGC now has a Market Capitalization of 22.24M and an Enterprise Value of 19.53M. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.23 while its Price-to-Book (P/B) ratio in mrq is 2.46. Its current Enterprise Value per Revenue stands at 14.55 whereas that against EBITDA is -1.90.
Stock Price History:
Over the past 52 weeks, IGC has reached a high of $0.49, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.2896, while the 200-Day Moving Average is calculated to be 0.3208.
Shares Statistics:
It appears that IGC traded 328.31K shares on average per day over the past three months and 428.93k shares per day over the past ten days. A total of 53.08M shares are outstanding, with a floating share count of 51.36M. Insiders hold about 19.42% of the company’s shares, while institutions hold 3.87% stake in the company. Shares short for IGC as of Feb 15, 2024 were 926.34k with a Short Ratio of 2.82, compared to 844.83k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.45% and a Short% of Float of 1.54%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.22 and -$0.22 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.16, with 1 analysts recommending between -$0.16 and -$0.16.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $1.4M in the next fiscal year. The high estimate is $1.4M and the low estimate is $1.4M. The average revenue growth estimate for next year is up 12.90% from the average revenue estimate for this year.
